对腹的治疗方法
Allison Ferris1, Polina Gaisinskaya2, Neilanjan Nandi3
1Internal Medicine Residency Program, Department of Medicine, Charles E. Schmidt College of Medicine, Florida Atlantic University, 800 Meadows Road, Boca Raton, FL 33486, USA.
Primary care
|July 29, 2023
概括
腹是影响生活质量和医疗保健使用的常见问题. 初级保健医生需要基于证据的方法来有效诊断和管理腹.
科学领域:
- 胃肠病学 胃肠病学
- 初级医疗保健医学 一级医疗保健医学
背景情况:
- 腹是常见的初级保健投诉,显著影响患者的福祉和医疗保健资源的利用.
- 虽然腹往往是急性和自我限制的,但它可能源于各种原因,其中一些导致严重疾病或死亡.
- 慢性腹需要进行彻底的调查,因为它可能表明潜在的严重疾病.
研究的目的:
- 为初级保健医生管理腹概述一种基于证据的和全面的方法.
- 强调在腹管理中适当分配医疗保健资源的重要性.
主要方法:
- 本摘要没有详细说明具体方法,但讨论了在初级保健中对腹的一般方法.
主要成果:
- 本摘要不介绍具体结果,但强调了腹的临床意义.
结论:
- 初级保健医生必须采用系统的,基于证据的策略来评估和治疗腹.
- 有效的腹管理对于优化患者护理和医疗资源分配至关重要.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
214
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
214
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
158
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
158
Irritable Bowel Syndrome III: Medical and Nursing Management
242
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
242
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
251
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
251
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152


